TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -2.70%799.36M | -5.44%1.68B | -8.32%821.5M | 1.91%1.78B | 11.31%896.04M | -20.53%1.74B | -44.59%804.99M | 18.65%2.19B | 63.47%1.45B | 7.34%1.85B |
Operating income | -2.70%799.36M | -5.44%1.68B | -8.32%821.5M | 1.91%1.78B | 11.31%896.04M | -20.53%1.74B | -44.59%804.99M | 18.65%2.19B | 63.47%1.45B | 7.34%1.85B |
Cost of sales | -5.34%-150.94M | 11.15%-299.85M | 6.92%-143.29M | 1.31%-337.5M | -5.47%-153.95M | 57.33%-341.98M | 77.67%-145.97M | -138.05%-801.4M | -268.77%-653.57M | 22.70%-336.65M |
Operating expenses | -5.34%-150.94M | 11.15%-299.85M | 6.92%-143.29M | 1.31%-337.5M | -5.47%-153.95M | 57.33%-341.98M | 77.67%-145.97M | -138.05%-801.4M | -268.77%-653.57M | 22.70%-336.65M |
Gross profit | -4.39%648.42M | -4.10%1.38B | -8.61%678.21M | 2.70%1.44B | 12.60%742.09M | 0.68%1.4B | -17.53%659.03M | -7.96%1.39B | 12.33%799.15M | 17.51%1.51B |
Selling expenses | -87.38%-19.62M | 33.15%-33.41M | 22.41%-10.47M | -25.63%-49.98M | 34.28%-13.49M | -7.34%-39.78M | 15.56%-20.53M | -16.73%-37.06M | -34.50%-24.32M | 15.27%-31.75M |
Administrative expenses | 25.00%-49.53M | 24.93%-135.98M | 10.67%-66.04M | 7.21%-181.13M | -0.31%-73.92M | 8.98%-195.21M | 20.08%-73.7M | 9.79%-214.46M | 20.33%-92.22M | 0.97%-237.75M |
Revaluation surplus | -79.78%-88.09M | -953.47%-191.26M | -352.82%-49M | --22.41M | --19.38M | ---- | ---- | -5.88%1.1B | ---- | 6.92%1.17B |
-Changes in the fair value of investment property | -79.78%-88.09M | -953.47%-191.26M | -352.82%-49M | --22.41M | --19.38M | ---- | ---- | -5.88%1.1B | ---- | 6.92%1.17B |
Special items of operating profit | -77.39%-110.86M | -363.37%-205.29M | -208.60%-62.49M | 290.01%77.95M | 181.80%57.54M | -119.77%-41.02M | -181.35%-70.35M | 85.07%207.52M | 229.55%86.48M | -91.55%112.13M |
Operating profit | -22.42%380.33M | -37.81%812.76M | -32.99%490.22M | 16.29%1.31B | 47.96%731.6M | -54.06%1.12B | -35.71%494.45M | -3.00%2.45B | -33.51%769.1M | -26.44%2.52B |
Financing income | 1.94%2.53M | 263.97%11.64M | 25.27%2.48M | -94.26%3.2M | -91.21%1.98M | -12.06%55.73M | -41.03%22.52M | -20.82%63.37M | -8.61%38.18M | -34.01%80.03M |
Financing cost | 5.01%-367.37M | 2.99%-778.19M | 8.08%-386.72M | 12.30%-802.22M | 6.35%-420.7M | 0.08%-914.68M | 4.34%-449.24M | -34.14%-915.37M | -40.90%-469.6M | -15.28%-682.4M |
Earning before tax | -85.38%15.49M | -90.90%46.21M | -66.13%105.98M | 91.78%507.82M | 361.93%312.88M | -83.39%264.79M | -79.94%67.73M | -16.94%1.59B | -60.97%337.67M | -35.11%1.92B |
Tax | -36.58%-124.66M | 48.96%-226.28M | 23.44%-91.28M | -14.04%-443.32M | 17.64%-119.23M | 63.21%-388.74M | -8.71%-144.76M | -76.34%-1.06B | 55.27%-133.16M | 40.60%-599.17M |
After-tax profit from continuing operations | -842.65%-109.17M | -379.16%-180.07M | -92.41%14.7M | 152.04%64.51M | 351.40%193.65M | -123.06%-123.95M | -137.67%-77.03M | -59.29%537.43M | -63.96%204.51M | -32.26%1.32B |
Earning after tax | -842.65%-109.17M | -379.16%-180.07M | -92.41%14.7M | 152.04%64.51M | 351.40%193.65M | -123.06%-123.95M | -137.67%-77.03M | -59.29%537.43M | -63.96%204.51M | -32.26%1.32B |
Minority profit | -249.31%-1.62M | -105.25%-173K | -64.74%1.09M | -53.86%3.3M | -3.23%3.08M | -9.11%7.15M | 399.37%3.19M | 170.40%7.86M | -77.41%638K | -147.15%-11.17M |
Profit attributable to shareholders | -890.02%-107.55M | -393.91%-179.9M | -92.86%13.61M | 146.69%61.21M | 337.57%190.57M | -124.76%-131.1M | -139.35%-80.22M | -60.22%529.57M | -63.90%203.87M | -30.85%1.33B |
Basic earnings per share | -0.02 | -400.00%-0.03 | 0 | 133.33%0.01 | 300.00%0.04 | -130.00%-0.03 | -150.00%-0.02 | -61.54%0.1 | -63.64%0.04 | -29.92%0.26 |
Diluted earnings per share | -0.02 | -400.00%-0.03 | 0 | 133.33%0.01 | 300.00%0.04 | -130.00%-0.03 | -150.00%-0.02 | -61.54%0.1 | -63.64%0.04 | -29.92%0.26 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.